These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3463630)

  • 1. [The phase I and early phase II studies of human lymphoblast interferon (MOR-22) in the treatment of malignant tumors].
    Tsubura E
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1049-58. PubMed ID: 3463630
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study of the clinical response of renal cell carcinoma to human lymphoblastoid interferon (MOR-22)].
    Niijima T
    Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1277-84. PubMed ID: 3782978
    [No Abstract]   [Full Text] [Related]  

  • 3. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
    Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
    J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
    Kotake T; Kinouchi T
    Prog Clin Biol Res; 1989; 303():661-9. PubMed ID: 2780667
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of metastatic renal cell carcinoma with human lymphoblastoid interferon].
    Ryu S; Fukuoka M; Tamai S; Takifuji N; Sakai N; Matsui K; Negoro S; Takada M; Kusunoki Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):996-1002. PubMed ID: 3694004
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
    Figlin RA; deKernion JB; Maldazys J; Sarna G
    Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effect of human lymphoblastoid interferon (MOR-22) on malignant skin tumors--a phase II study].
    Mishima Y
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1059-67. PubMed ID: 3760649
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effect of human lymphoblastoid interferon (MOR-22) on malignant brain tumors--a phase II study].
    Hirakawa K
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1068-74. PubMed ID: 3760650
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical effects and immunological changes in interferon therapy for advanced renal cell carcinoma].
    Kudo T; Souma H; Kudo S; Kogawa T; Suzuki T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):40-6. PubMed ID: 2109026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of interferon-beta (MR-21) in renal cell carcinoma and cancer of the bladder].
    Niijima T
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):928-33. PubMed ID: 3694001
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phase II trial of treatment of metastatic renal adenocarcinoma with recombinant leukocyte interferon (rDNA IFN-alpha 2)].
    Dorval T; Palangie T; Garcia-Giralt E; Jouve M; Bretaudeau B; Falcoff F; Coninx P; Schwab D; Pouillart P
    Bull Cancer; 1985; 72(5):470-1. PubMed ID: 4074917
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R; Scheithauer W; Ludwig H; Flener R
    Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of streptozocin in the treatment of advanced renal cell carcinoma.
    Licht JD; Garnick MB
    Cancer Treat Rep; 1987 Jan; 71(1):97-8. PubMed ID: 2947680
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of established human renal cell carcinoma--experimental treatment with interferon and UFT].
    Onishi T; Iizuka N; Suzuki M; Mori Y; Kondo I; Nakada J; Masuda F; Machida T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1498-502. PubMed ID: 3141533
    [No Abstract]   [Full Text] [Related]  

  • 15. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma.
    Wagner H; Possinger K; Bremer K; Donhujsen-Ant R; Peukert M; Queisser W
    Cancer Treat Rep; 1987 Feb; 71(2):209-10. PubMed ID: 3802118
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of renal cell carcinoma. 3. Interferon therapy].
    Kobayashi M; Imai K; Kiren H; Nakai K; Saruki K; Umeyama T; Ito Y; Yamanaka H; Makino T; Machida M
    Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.
    Rinehart J; Malspeis L; Young D; Neidhart J
    Cancer Res; 1986 Oct; 46(10):5364-7. PubMed ID: 3756886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant interferon-alpha 2a and vinblastine in advanced renal cell cancer: a clinical phase I-II study.
    Kellokumpu-Lehtinen P; Nordman E
    J Biol Response Mod; 1990 Aug; 9(4):439-44. PubMed ID: 2395008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of taxol in patients with metastatic renal cell carcinoma.
    Einzig AI; Gorowski E; Sasloff J; Wiernik PH
    Cancer Invest; 1991; 9(2):133-6. PubMed ID: 1677827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.